Closing Bell: Amylyx Pharmaceuticals Climbs, Targa Rises, Klarna Plunges
Today's biggest winners and losers in the stock market.On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Isabelle Lee, Carol Massar and Joe Deaux- Amylyx Pharmaceuticals (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.